Toxicology and Epidemiology: Improving the Science with a Framework for Combining Toxicological and Epidemiological Evidence to Establish Causal Inference

Toxicological Sciences - Tập 122 Số 2 - Trang 223-234 - 2011
Hans‐Olov Adami1,2, Colin Berry3, Charles B. Breckenridge4, Lewis L. Smith5,6, James A. Swenberg7, Dimitrios Trichopoulos1, Noel S. Weiss8,9, Timothy P. Pastoor4
1Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02215
2Department of Medical Epidemiology and Biostatistics, Karolinska Intitutet, Stockholm, Sweden
3Queen Mary University, London, UK
4Toxicology & Health Sciences Department, Syngenta Crop Protection, Greensboro, North Carolina 27419
5MRC Toxicology Unit The College of Medicine, University of Leicester, Leicester, UK
6Syngenta Crop Protection Ltd, Basle, Switzerland
7Department of Environmental Sciences and Engineering, University of North Carolina, Chapel Hill, North Carolina 27599
8Department of Epidemiology, University of Washington, Seattle, Washington 98195
9the Fred Hutchinson Cancer Research Center, Seattle, Washington 98109

Tóm tắt

Từ khóa


Tài liệu tham khảo

1964, Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service

2006, IPCS framework for analyzing the relevance of a cancer mode of action for humans, Crit. Rev. Toxicol, 36, 781, 10.1080/10408440600977677

2008, IPCS framework for analyzing the relevance of a noncancer mode of action for humans, Crit. Rev. Toxicol, 38, 87, 10.1080/10408440701749421

2003, The human relevance of information on carcinogenic modes of action: overview, Crit. Rev. Toxicol., 33, 581, 10.1080/713608371

2006, Breast cancer, Cancer Epidemiology and Prevention

1997, Causality in epidemiology, health policy and law, Environ. Law Rep, 27, 10279

ECETOC, 2009, Framework for the Integration of Human and Animal Data in Chemical Risk Assessment

1989, New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association, J. Am. Med. Assoc., 261, 2517, 10.1001/jama.1989.03420170061031

1995, The role of epidemiology in regulatory risk assessment

2005, Evidence-based toxicology: a comprehensive framework for causation, Hum. Exp. Toxicol., 24, 161, 10.1191/0960327105ht517oa

1982, Reye's syndrome and medication use, J. Am. Med. Assoc.,, 248, 687, 10.1001/jama.1982.03330060027028

1965, The environment and disease: association or causation, Proc. R. Soc. Med., 58, 295

1996, Cohort studies of fat intake and the risk of breast cancer—a pooled analysis, N. Engl. J. Med., 334, 356, 10.1056/NEJM199602083340603

1987, Public Health Services study of Reye's syndrome and medication. Report of the main study, J. Am. Med. Assoc., 257, 1905, 10.1001/jama.1987.03390140075030

IARC, 2001, Phenobarbital and Its Sodium Salts. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans., 161

2009, The key events dose-response framework: a cross-disciplinary mode-of-action based approach to examining dose-response and thresholds, Crit. Rev. Food Sci. Nutr., 49, 682, 10.1080/10408390903110692

2009, Future needs of occupational epidemiology of extremely low frequency electric and magnetic fields: review and recommendations, Occup. Environ. Med, 66, 72

2008, Occupational electromagnetic fields and leukemia and brain cancer: an update to two meta-analyses, J Occup Environ Med, 50, 677, 10.1097/JOM.0b013e3181757a27

2003, PPAR alpha agonist-induced rodent tumors: modes of action and human relevance, Crit. Rev. Toxicol, 33, 655, 10.1080/713608372

1884, Die Aetiologie der Tuberkulose, Mitt Kaiser Gesundh, 2:1

1893, Über den augenblicklichen Stand der bakteriologischen Choleradiagnose (in German), Zeitschrift für Hygiene und Infectionskrankheiten, 14, 319, 10.1007/BF02284324

2007, Causality and the interpretation of epidemiological evidence, Environ. Health Perspect., 114, 969

2005, Causality in cancer epidemiology, Eur. J. Epidemiol., 20, 565, 10.1007/s10654-005-7968-y

London Principles, 1996, The London Principles for Evaluating Epidemiologic Data in Regulatory Risk Assessment

2003, A framework for human relevance analysis of information on carcinogenic modes of action, Crit. Rev. Toxicol., 33, 591, 10.1080/713608373

2005, Historical perspective of the cancer bioassay, Scand. J. Work Environ. Health, 31, 129

2004, The missed lessons of Sir Austin Bradford Hill, Epidemiol. Perspect. Innov., 1, 3, 10.1186/1742-5573-1-3

1959, The Logic of Scientific Discovery

1962, Percivall Pott's contribution to cancer research, NCI Monograph, 10, 1

1994, A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China, Cancer Epidemiol. Biomarkers Prev., 3, 3

1976, Causes, Am. J. Epidemiol., 104, 578

2005, Causation and causal inference in epidemiology, Am. J. Public Health, 95, S144, 10.2105/AJPH.2004.059204

2002, Virology, pathogenic mechanisms and associated diseases of Kaposi sarcoma-associated herpesvirus (Human herpesvirus 8), Mayo Clin. Proc., 77, 941, 10.1016/S0025-6196(11)62261-1

2005, Overview: using mode of action and life stage information to evaluate the human relevance of animal toxicity data, Crit. Rev. Toxicol., 35, 663, 10.1080/10408440591007133

2011, Atrazine and breast cancer: a framework assessment of the toxicological and epidemiological evidence, Tox. Sci.

2001, IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis, Regul. Toxicol. Pharmacol, 34, 146, 10.1006/rtph.2001.1493

1986, The logic of Sir Karl Popper and the practice of epidemiology, Am. J. Epidemiol, 124, 711, 10.1093/oxfordjournals.aje.a114446

1999, α2 Urinary-globulin-associated nephropathy as a mechanism of renal tubule cell carcinogenesis in male rats, Species Differences in Thyroid Kidney and Urinary Bladder Carcinogenesis. IARC Scientific Publications No. 147

1981, Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline, Lancet, 2, 567

1989, Human carcinogens so far identified, Jpn J Cancer Res, 80, 795, 10.1111/j.1349-7006.1989.tb01717.x

U.S. Environmental Protection Agencty (USEPA), 1993, Pesticide Reregistration Rejection Rate Analysis—Toxicology

U.S. Environmental Protection Agencty (USEPA), 2001, HED Standard Operating Procedure: Executive Summaries for Toxicology Data Evaluation Records (DERs)

2007, The strengthening of the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies, PLoS Med, 4, 1623

1996, Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan, Int. J. Cancer, 67, 620, 10.1002/(SICI)1097-0215(19960904)67:5<620::AID-IJC5>3.0.CO;2-W

2005, Weight of evidence: a review of concepts and methods, Risk Anal., 25, 1545, 10.1111/j.1539-6924.2005.00699.x

1996, Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation and tumor promotion, Pharmacol. Ther., 71, 153, 10.1016/0163-7258(96)00067-8

1984, Identification of chemicals carcinogenic to man, Toxicol. Pathol., 12, 397, 10.1177/019262338401200415

World Health Organization, 2009, Report of a WHO expert meeting in collaboration with FAO supported by Heath Canada. Toxicological and Health Aspects of Melamine and Cyanuric Acid

1918, Experimental study of the pathogenesis of carcinoma, J. Cancer Res., 3, 1